Last quarter (Q3 2024), Rakovina Therapeutics Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Rakovina Therapeutics Inc's net income was $-1.02M. See Rakovina Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Dec 22
Dec 21
Total Revenue
$ ―
$ ―
$ ―
Gross Profit
$ ―
$ ―
$ ―
Operating Expenses
$ ―
$ ―
$ ―
Depreciation and Amortization
$ 536.11K
$ 536.11K
$ ―
EBITDA
$ -1.93M
$ -2.26M
$ -5.11M
Operating Income
$ -2.48M
$ -2.82M
$ -2.47M
Other Income/Expenses
$ ―
$ ―
$ ―
Pretax Income
$ ―
$ ―
$ ―
Net Income
$ -2.61M
$ -2.79M
$ -5.52M
Per Share Metrics
Basic EPS
$ ―
$ ―
$ ―
Diluted EPS
$ ―
$ ―
$ ―
Weighted Average Shares Outstanding
―
―
―
Weighted Average Shares Outstanding (Diluted)
―
―
―
Currency in USD
Rakovina Therapeutics Inc Earnings and Revenue History